Restaurants have turned to GoFundMe during the pandemic. They shouldn’t have to.

As restaurants adapt to the Covid-19 pandemic, an already precarious industry turns to crowdfunding. | Getty Images

The crowdfunding platform was a lifeline for independently owned businesses. But why?

There’s a three-block stretch in Crown Heights, Brooklyn, that contains, by my count, 19 restaurants. It’s the best: If you want margaritas and Mexican food, you can order a pitcher at a colorfully tiled table outside at Chavela’s. 95 South has the best to-go rum punch in the neighborhood. For plant-based Ethiopian, there’s Ras, which is a few doors down from Suya, a Nigerian counter joint that makes super spicy steak bowls. No weekend morning is complete without a bacon-egg-and-cheese from Bagel Pub (the best in Brooklyn, no offense).

If I sound biased it’s because I live there, on the residential street one block away. I moved in on the first of March, thrilled to be surrounded by so many places I couldn’t wait to try. It was horrible timing, of course. Two weeks later, every single one of them was closed.

Like so many small businesses all over the country, the restaurants of Franklin Avenue were left mostly helpless. On March 18, Gov. Andrew Cuomo ordered nonessential businesses to reduce their in-person staff by 50 percent. Owners faced an impossible choice: Attempt to stay open and risk the health and safety of their employees and customers, or close down, leaving everyone unemployed. By March 20, they wouldn’t have to make that choice, as all nonessential businesses were shuttered.

With no way to pay staff or rent, almost all of them turned to the internet. “I work in the service industry, and so many of my friends on my Facebook wall were sharing [links] to please donate to staff,” recalls Zhenya Kampanets, co-owner of Crown Inn, a cozy bar on the strip. “It must be a pretty overwhelming experience, seeing so many places being like, ‘Please help us, please help us’” — especially, she acknowledges, when customers might be facing financial issues as well.

The pandemic fundraising platform of choice, it seemed, was GoFundMe, which like Kickstarter and IndieGoGo is often marketed as a launching pad for startup businesses or charities. But it often ends up as a depressing reminder of where the American social safety net fails — fundraisers for insurmountable health care bills, for example, are incredibly common. “The GoFundMe homepage features fundraising pitches that hit virtually every bullet point in the United Nation’s list of basic human rights,” notes a scathing appraisal of the crowdfunding economy in Jacobin magazine. The coronavirus, naturally, was a boon for the platform, which saw its greatest demand since it launched in 2010.

Crown Inn launched its own GoFundMe page on March 20, with a $10,000 goal in which all donations would go to bartenders, barbacks, and porters. “I did feel a little conflicted about it, because I kept hearing stories about people losing their jobs and it felt a bit strange asking people for money,” Kampanets says. “You don’t know people’s situations. But I felt that if there’s anything we can do to help the people who work behind the bar, we should do that.”

GoFundMe may also be the most fundraiser-friendly of the crowdfunding platforms, not only because of its high name recognition. In 2017, it removed the platform fee, which previously allowed the company to pocket five percent of every donation. There still remains a fee of 2.9 percent plus 30 cents per donation to cover payment processing, and donors are given an option to “tip” the company when they contribute to a cause. The users I spoke with had only positive experiences on the platform, though other owners have reported difficulties with its strict identity verification system. Like almost all of its neighbors, Crown Inn only reached about one-third of its goal (crowdfunders can still access their money whether its goal is reached or not). This is common: In normal times, about 27 percent of GoFundMe campaigns hit their goal, according to researchers at the University of Rochester, but that number is likely worse now.

GoFundMe campaigns typically fare better when they’ve built a community of local or online fans. On Franklin Ave, owners told me, people are quick to rally around their favorite spots. “We had regulars who were so incredibly generous with us that it almost felt like an, ‘Oh my god, this is too much,’ type of thing,” says Kampanets. “Honestly, I was so grateful for people who were donating five or ten bucks, because that’s what they could do. We had several people who, when we reopened, came back and they said, ‘I’m sorry, I couldn’t donate, I lost my job’ but then they tipped extra once we came back. That was a really sweet thing.”

The kind gestures from regular customers were in stark contrast to how the federal and state governments were handling the crisis. “So much political infighting stalled any progress for relief, which is still frustrating,” explains Claire Sprouse, owner of the nearby all-day cocktail bar and restaurant Hunky Dory. “At the federal level, we should have had the infrastructure to handle unemployment claims. I have employees who weren’t able to collect funds for two months. It’s a major clusterfuck.” Sprouse and Kampanets were both ultimately able to receive Paycheck Protection Program (PPP) loans, though hundreds of thousands of other small businesses haven’t been so lucky.

“In the early days, it was difficult to understand whether we’re going to be able to get [the loan], how much it was going to be, or how it was going to work,” says Kampanets. “The website kept crashing, because so many businesses were applying.”

“It quickly became clear to us that businesses didn’t know where to turn,” says Samara Karasyk, the chief policy officer at the Brooklyn Chamber of Commerce. “The first round of PPP loans missed all of our small businesses, and these programs weren’t working. If you didn’t have a pre-existing relationship with the bank, they weren’t talking to you.” The Chamber of Commerce ultimately launched its own crowdfunding campaign to raise money for the Bring Back Brooklyn fund, which gives microloans to mostly minority- and women-owned businesses.

Restaurants and their employees are uniquely affected by economic slowdowns. “In an industry where a lot of the workers are from our most vulnerable communities and are living on a cash economy, that income is based on everything from the weather to the subjective experience that a person has when you serve them,” Sprouse says. “That in itself doesn’t make a great foundation for people to be able to plan for their own safety and long-term future. On top of that, you have businesses that are running on razor thin margins and dealing with expensive rent that far outweighs the cost of doing business a lot of the time.” Workers, many of whom may be undocumented or living in small spaces with others, are also often the people more likely to contract Covid-19 on the job, and be more at risk once they get it.

Pumpkin Patch Patio because why the heck not?

A post shared by Hunky Dory (@hunkydorybk) on Oct 3, 2020 at 9:56am PDT

By April, Hunky Dory was able to give $400 to every employee who was able to receive unemployment and $1,000 to its undocumented workers who weren’t from the proceeds of its GoFundMe page, even though it only reached about a quarter of its goal. Now, Sprouse is concentrating her efforts on connecting with local restaurants. “You have the airline industry and the cruise ship industry who are getting all this assistance, because these are industries that have a history of organizing to advocate for themselves,” she explains. “We’ve been two steps behind.”

At least one of the Franklin Avenue restaurants has closed: Gladys’, a beloved Caribbean spot. Owner William Garfield told Eater that it was a combination of the coronavirus and failed negotiations with landlords that forced the closure in late June. In the early days of the pandemic, it too had set up a GoFundMe page for staff.

That businesses have to resort to GoFundMe at all is itself evidence of a larger systemic failure. Restaurants, of course, were not the only businesses turning to crowdfunding: hair salons, movie theaters, record shops, and bookstores have all launched their own campaigns. But restaurants were already in a precarious industry before the pandemic, and as Priya Krishna argues in the New York Times, “Every restaurant should be able to find a model narrowly tailored to its workers and community, so long as there is also a broader public safety net. For an industry-wide shift to take place, some government assistance will be essential.” One food industry consulting firm estimated that between 20 and 25 percent of independent restaurants will never reopen.

For now, many of the restaurants on Franklin Ave have ample outdoor seating and appear bustling and busy, albeit socially distanced. By raising its prices and incorporating gratuity and sales tax into the cost, Hunky Dory has been able to avoid losing money. But in a business where margins are already thin, no amount of customers can make up for months of closed doors and the uncertainty of winter, where in New York it’s frequently too cold to sit outside. If PPP loans aren’t made more widely available, more businesses may have to resort to crowdfunding on platforms like GoFundMe. But, as Kampanets says, “I’m hoping we don’t have to do it again.”


Help keep Vox free for all

Millions turn to Vox each month to understand what’s happening in the news, from the coronavirus crisis to a racial reckoning to what is, quite possibly, the most consequential presidential election of our lifetimes. Our mission has never been more vital than it is in this moment: to empower you through understanding. But our distinctive brand of explanatory journalism takes resources. Even when the economy and the news advertising market recovers, your support will be a critical part of sustaining our resource-intensive work. If you have already contributed, thank you. If you haven’t, please consider helping everyone make sense of an increasingly chaotic world: Contribute today from as little as $3.

Sorrento Adds Stem Cell Treatment To Covid-19 Pipeline; Shares Rise

Sorrento Adds Stem Cell Treatment To Covid-19 Pipeline; Shares RiseShares in Sorrento rose 2.7% in Monday’s extended market session after the company entered into an exclusive license agreement with Personalized Stem Cells (PSC) to buy the global rights to its adipose derived mesenchymal stem cells (MSCs) to treat patients suffering from COVID-19 acute respiratory distress syndrome (ARDS).Sorrento (SRNE) said that the MSC program has been cleared for a Phase 1 clinical trial by the US Food and Drug Administration to the pipeline of COVID-19 focused rescue therapies. As part of the agreement, the company will conduct the Phase 1 trial, which is targeted to enroll about 20 hospitalized COVID-19 patients in California. Pending the results of the Phase 1 trial, Sorrento expects to expand into Phase 2 trials in multiple relevant geographies in consultation with regulatory authorities.Sorrento noted that stem cells have shown to support resolution of symptoms in multiple disease settings and have the potential to reduce the long-term effects associated with pulmonary tissue damage for patients. More specifically, the company believes that stem cells have a high potential to help in the fight against COVID-19 as a stand-alone therapy or in synergy with other product candidates in its pipeline, including small molecules (abivertinib or salicyn-30) and neutralizing antibodies (STI-1499 or STI 2020).“Stem cells were a missing piece in our comprehensive portfolio of potential solutions against COVID-19. We now cover multiple stages of the continuum of care from prevention to potential therapeutic solutions for the most advanced stages of the disease,” said Sorrento CEO Henry Ji. “With PSC’s Phase 1 product candidate, we hope to move quickly through the next clinical trials, and, if successful, be able to provide a supportive therapy that may save the lives of the most advanced patients and may also ensure patients who have to undergo intensive care can benefit from a therapy with the potential to minimize the long-term effects of the disease due to the lung damage created by the virus early in the infection.”The single arm, non-randomized Phase 1 study will evaluate the safety and preliminary efficacy of an adipose-derived allogeneic MSC product candidate. The outcome data will be compared to contemporaneous non-enrolled patients at the same clinical site as the enrolled patients.The primary objective is to test the safety of intravenous infusion of allogeneic adipose stem cells in patients with COVID-19 and in respiratory distress. The secondary objective is to trial a set of safety and efficacy outcome variables to give guidance regarding the risk/benefit ratio in patients with COVID-19 respiratory distress.Sorrento has received two recent Buy ratings from the Street, with Dawson James publishing a $21 price target (84% upside potential) and HC Wainwright setting a more bullish $30 price target (163% upside potential).That’s with shares already up almost 234% year-to-date, boosted by investor optimism for Sorrento’s COVID-19 candidates including its COVI-SHIELD, an antibody cocktail treatment. Dawson James’ Jason Kolbert said he assumes that the company will successfully develop COVI-Shield (and non-opioid Pain Medication, RTX).“We apply a probability of success of just 50%, but given the size of the indication, the valuation potential for COVID alone is significant,” Kolbert wrote in a note to investors. “For Sorrento, we additionally apply a 30% discount rate. Our valuation conclusion is an equally-weighted average of our FCFF, EPS, and sum-of-the-parts analysis rounded to the nearest whole number.” (See SRNE stock analysis on TipRanks).Related News: J&J Halts Covid-19 Vaccine Trial Due To ‘Unexplained Illness’ Opko’s BioReference Lab Begins Covid-19 Testing At NYC Schools Pfizer, BioNTech Initiate Rolling Canada Submission For Covid-19 Vaccine More recent articles from Smarter Analyst: * Nestlé Completes Tender Offer For 84% Stake In Aimmune Therapeutics * New Oriental Rises On Solid Earnings Beat Despite Covid-Headwinds * Altimmune’s COVID-19 Vaccine Shows Positive Results; Street Sees 289% Upside * Sanofi, Regeneron’s Dupixent Significantly Reduces Children’s Asthma Attacks

BofA Analyst: Canopy Poised For Growth As Democrats Hope For Marijuana Legalization

BofA Analyst: Canopy Poised For Growth As Democrats Hope For Marijuana LegalizationAs the 2020 election heats up, Smith Falls, Ontario-based Canopy Growth Corp. (TSX: WEED)(NYSE: CGC) is hustling to gai additional U.S. market access, according to a Bank of America Global Research analysis.The year-long process to acquire New York-based Acreage Holdings, Inc. (CSE: ACRG.U) (OTCQX: ACRHF) is giving results, as the cannabis companies agreed to introduce the Tweed brand in several U.S. states.Moreover, Canopy inked a loan financing deal worth CA$80.5 million ($58.59 million) with TerrAscend Corp.’s (OTCQX: TRSSF) subsidiary, earlier this year. In addition, it strengthened its presence in the U.S. by the launch of its new e-commerce website — ShopCanopy.com. Post-Election OutlookBofA analysts Bryan Spillane and Lisa Lewandowski wrote in a Monday note that cannabis legalization would be the “major political issue,” following the U.S. presidential election between President Donald Trump and Former Vice President Joe Biden.”We don’t expect a debate on whether the U.S. will legalize cannabis on a federal level in all jurisdictions, but rather for the federal government to defer to states, with a federal framework,” the analysts said.Certain issues would be clarified if the Congress and/or the White House moves “in favor of the Democrats.” They include: * Banking reform (the SAFE Banking Act) * Elimination of cannabis from Schedule 1 of the Controlled Substances Act * Resolution of conflicts between federal and state laws * Criminal Justice Reform * Access to cannabis for veteransHigh-Profile Ballot Measures Meantime, voters across the four states are deciding on seven ballot measures regarding marijuana.Mississippi and South Dakota would decide on legalizing medical marijuana. Arizona, Montana, New Jersey, and South Dakota would vote on the recreational use of cannabis. Montana is poised to define a legal age for marijuana.Analysts believe that New Jersey and Arizona would be “the most important cannabis-related ballot measures to watch.”If NJ voters pass the initiative, New York, Connecticut, Pennsylvania, and Rhode Island would gain “momentum to pass,” they anticipate.Arizona‘s ballot measure — if passed — would allow “5 contiguous Western states (>60mn people)” to “have full adult use legalization,” analysts added.”Mississippi shifting to medical use would build on other conservative states,” including Oklahoma, Arkansas, and Utah, which allow the medical use of cannabis, they disclosed.Recreational And Medical UseThe recreational use of marijuana is legalized in 11 states and the District of Columbia, so far, including nine states that achieved the goal by citizen initiatives and two through bills. In addition, adult-use cannabis is available to 28% of the population.Currently, 33 states and the District of Colombia have either legalized or decriminalized the medical use of cannabis, with 65% of the population having access. In 13 states, the use of cannabidiol (CBD) for medical purposes is legal.Courtesy imageLatest Ratings for CGC DateFirmActionFromTo Feb 2020Stifel NicolausMaintainsBuy Jan 2020BMO CapitalUpgradesMarket PerformOutperform Nov 2019Bank of AmericaUpgradesNeutralBuy View More Analyst Ratings for CGC View the Latest Analyst Ratings See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Canopy Rivers Provides DIP Financing For PharmHouse’s Restructuring * Martha Stewart Introduces CBD Product Line Via Partnership With Canopy Growth(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Cloudflare Soars 23% After Cloud Platform Launch

Cloudflare Soars 23% After Cloud Platform LaunchShares of Cloudflare soared 23% on Monday following the cloud computing company’s launch of its new cloud-based platform Cloudflare One. The network-as-a-service platform promises to secure and connect companies and remote working teams anywhere and on any device.Cloudflare (NET) said in a blog posted on its website that Cloudflare One “replaces a patchwork of appliances and WAN technologies with a single network that provides cloud-based security, performance, and control through one user interface.”The company also said that it has integrated the Cloudflare One platform with all major providers of identity management and device-security solutions. Microsoft Active Directory, Google Workspace, Okta and Ping Identity are some of the notable providers of Cloudflare One. (See NET stock analysis on TipRanks)On Oct. 5, Robert W. Baird analyst Jonathan Ruykhaver reiterated a Buy rating on the stock with a price target of $48 (15.8% downside potential). In a note to investors, Ruykhaver said, “While we believe companies are likely to employ a hybrid infrastructure, we do see a continued shift to the cloud in security and believe Cloudflare is positioning itself to take advantage of this trend. We also believe Cloudflare is positioning itself for further growth and share gains from its performance and reliability portfolio of products.”Currently, the Street has a bullish outlook on the stock. The Strong Buy analyst consensus is based on 9 Buys and 2 Holds. With shares up over 234% year-to-date, the average price target of $48.56 implies downside potential of 14.8% to current levels.Related News: Workhorse Secures $200M Financing To Boost Production; Shares Up 774% YTD Twilio Stock Gains 7.7% On $3.2B Segment Deal; Street Stays Bullish PerkinElmer Raises 3Q Sales Outlook Fueled By COVID-19 Testing Demand More recent articles from Smarter Analyst: * Nestlé Completes Tender Offer For 84% Stake In Aimmune Therapeutics * New Oriental Rises On Solid Earnings Beat Despite Covid-Headwinds * Altimmune’s COVID-19 Vaccine Shows Positive Results; Street Sees 289% Upside * Disney Plans Major Shake-Up To Focus On Streaming Business

Workhorse Secures $200M Financing To Boost Production; Shares Up 774% YTD

Workhorse Secures $200M Financing To Boost Production; Shares Up 774% YTDWorkhorse on Monday said that it has secured $200 million in financing through entering into a note purchase agreement (NPA) with two institutional lenders to increase production volumes. Under the NPA, the drone-integrated electric vehicle manufacturer will sell $200 million worth of senior notes carrying an annualized interest rate of 4% and maturing in 2024.Apart from accelerating production volumes, Workhorse (WKHS) intends to use the proceedings to “advance new products to market, replace previous higher cost financings, and support current working capital and other general corporate purposes.” According to the NPA, the company can pay interest in cash or stock and the interest rate could be reduced to 2.75% upon meeting certain conditions.The company expects to generate $194.5 million in net proceeds from the notes offering. The NPA deal provides lenders with an option to exchange the notes for company stock at $36.14 per share, a 35% premium to the October 9 closing price of $26.77. (See WKHS stock analysis on TipRanks).On Sept. 2, Oppenheimer analyst Colin Rusch initiated coverage on Workhorse with a Buy rating and a price target of $23 (14.1% downside potential). In his note to investors, Rusch wrote, “With multiple catalysts in front of the stock, including the potential for an award from the US Postal Service, ramp of licensee Lordstown Motors, and delivery against its own pipeline of orders, we see WKHS shares as having short-term upside with optionality on long-term growth.”Currently, the Street has a bullish outlook on the stock. The Strong Buy analyst consensus is based on 3 Buys and 1 Hold. With shares up over 774% year-to-date, the average price target of $25.33 implies downside potential of 4.7% to current levels.Related News: GM China 3Q Vehicle Sales Jump 12%; Merrill Lynch Sees 87% Upside Tesla Mulls LG Chem Investment To Boost Battery Supply- Report Daimler, Swiss Re Form Mobility Insurance JV; Goldman Double Upgrades To Buy More recent articles from Smarter Analyst: * New Oriental Rises On Solid Earnings Beat Despite Covid-Headwinds * Altimmune’s COVID-19 Vaccine Shows Positive Results; Street Sees 289% Upside * Sanofi, Regeneron’s Dupixent Significantly Reduces Children’s Asthma Attacks * Disney Plans Major Shake-Up To Focus On Streaming Business